Adjuvant or neoadjuvant treatment with immune checkpoint inhibitors: re-assessing the risk-benefit ratio
- PMID: 38012894
- DOI: 10.1016/S1470-2045(23)00575-2
Adjuvant or neoadjuvant treatment with immune checkpoint inhibitors: re-assessing the risk-benefit ratio
Conflict of interest statement
We declare no competing interests.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources